Drug intelligence / Profile preview

VAXXITEK

Development stage: Unknown
Lead developer: Boehringer Ingelheim Animal Health
Modality: Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Administration: In Ovo, Subcutaneous

Overview

VAXXITEK is a brand of veterinary vaccines developed and manufactured by Boehringer Ingelheim Animal Health, primarily for use in chickens. The VAXXITEK portfolio utilizes recombinant Herpesvirus of turkeys (HVT) as a vector to deliver protective antigens against various poultry diseases. Key formulations include VAXXITEK HVT+IBD, which protects against Infectious Bursal Disease (IBD) and Marek's Disease (MD), and extended versions like VAXXITEK HVT+IBD+ILT and VAXXITEK HVT+IBD+ND, offering additional protection against Infectious Laryngotracheitis (ILT) and Newcastle Disease (ND), respectively. These vaccines are typically administered in ovo or subcutaneously to one-day-old chicks to establish early and long-lasting immunity.

Brand names: VAXXITEK HVT+IBDVAXXITEK HVT+IBD+ILTVAXXITEK HVT+IBD+ND

Beyond the preview

Go deeper on VAXXITEK.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VAXXITEK.

Explore the full profile